Search

Your search keyword '"Robert T. Nolte"' showing total 40 results

Search Constraints

Start Over You searched for: Author "Robert T. Nolte" Remove constraint Author: "Robert T. Nolte"
40 results on '"Robert T. Nolte"'

Search Results

1. Potent Long-Acting Inhibitors Targeting the HIV-1 Capsid Based on a Versatile Quinazolin-4-one Scaffold

2. Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.

3. BacMam production and crystal structure of nonglycosylated apo human furin at 1.89 Å resolution

4. Dolutegravir interactions with HIV-1 integrase-DNA: structural rationale for drug resistance and dissociation kinetics.

5. A knowledge-based, structural-aided discovery of a novel class of 2-phenylimidazo[1,2-a]pyridine-6-carboxamide H-PGDS inhibitors

6. The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors

7. Allosteric Inhibition of Human Immunodeficiency Virus Integrase

8. Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase

9. Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop

10. Rational Design of Potent Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase

11. Structure of Rev-erbα bound to N-CoR reveals a unique mechanism of nuclear receptor–co-repressor interaction

12. Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroups

13. Discovery of Novel Benzimidazoles as Potent Inhibitors of TIE-2 and VEGFR-2 Tyrosine Kinase Receptors

14. Co-crystal structure guided array synthesis of PPARγ inverse agonists

15. Orally active 4-amino-5-diarylurea-furo[2,3-d]pyrimidine derivatives as anti-angiogenic agent inhibiting VEGFR2 and Tie-2

16. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRγ

17. Discovery of a novel and potent series of dianilinopyrimidineurea and urea isostere inhibitors of VEGFR2 tyrosine kinase

18. Discovery and Evaluation of 2-Anilino-5-aryloxazoles as a Novel Class of VEGFR2 Kinase Inhibitors

19. The Crystal Structure of Nucleoplasmin-Core

20. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation

21. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators

22. Discovery of Small Molecule RIP1 Kinase Inhibitors for the Treatment of Pathologies Associated with Necroptosis

23. Dolutegravir interactions with HIV-1 integrase-DNA: structural rationale for drug resistance and dissociation kinetics

24. Structure of the IRS-1 PTB Domain Bound to the Juxtamembrane Region of the Insulin Receptor

25. Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy

26. Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor

27. X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation

29. Crystallization of protein-ligand complexes

30. Crystal structures of the catalytic domain of phosphodiesterase 4B complexed with AMP, 8-Br-AMP, and rolipram

31. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha

32. Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity

33. Crystal structure of the pleckstrin homology-phosphotyrosine binding (PH-PTB) targeting region of insulin receptor substrate 1

34. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

35. Differing roles for zinc fingers in DNA recognition: structure of a six-finger transcription factor IIIA complex

36. Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes

37. Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor.

39. The amino blocking reagent 1-isopropyl-3-ethoxy-4-nitro-2-oxo-3-pyrroline and the N-hydroxysuccinimide esters of N-(1-cyclohexyl- and 1-isopropyl-4-nitro-2-oxo-3-pyrrolin-3-yl)glycine. Reagents for the introduction of N-glycyl residues

40. The complete sequence and structural analysis of human apolipoprotein B-100: relationship between apoB-100 and apoB-48 forms

Catalog

Books, media, physical & digital resources